aminophylline has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jayashree, P; Khurana, S; Lewis, LES; Ramesh Bhat, Y; Shivakumar, M; Sujith Kumar Reddy, GV | 1 |
| Cheng, SC; Huang, LT; Hung, PL; Lai, MC; Liou, CW; Wang, TJ; Wu, CL; Yang, SN | 1 |
1 trial(s) available for aminophylline and Cognition Disorders
| Article | Year |
|---|---|
Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
Topics: Aminophylline; Apnea; Caffeine; Child Development; Cognition Disorders; Developmental Disabilities; Female; Hearing Disorders; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Language Development Disorders; Male; Motor Disorders; Purinergic P1 Receptor Antagonists; Survival Rate; Time Factors; Vision Disorders | 2017 |
1 other study(ies) available for aminophylline and Cognition Disorders
| Article | Year |
|---|---|
Aminophylline aggravates long-term morphological and cognitive damages in status epilepticus in immature rats.
Topics: Aging; Aminophylline; Animals; Cell Differentiation; Cognition Disorders; Growth Cones; Hippocampus; Lithium Compounds; Male; Maze Learning; Mossy Fibers, Hippocampal; Muscarinic Agonists; Nerve Degeneration; Neuronal Plasticity; Neurons; Phosphodiesterase Inhibitors; Pilocarpine; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Seizures; Status Epilepticus | 2002 |